Potassium bicarbonate

碳酸氢钾

Report date: 2023/02/04 20:39:13
NME

Base Information

Drug NamePotassium bicarbonate
Drug Alias Name重碳酸钾Xosten
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFractures, BoneSarcopeniaOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChurch & DwightUc San Francisco
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTufts University
Active IndicationsN/A
Inactive IndicationsFractures, BoneSarcopeniaOsteoporosis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG